RCUS — Arcus Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Arcus Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	188	729	499	1,009	759
Net Total Accounts Receivable
Net Total Receivables	0.132	1.7	747	39	42
Prepaid Expenses
Total Current Assets	193	736	1,262	1,067	831
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.33	23.6	137	135	143
Long Term Investments
Other Long Term Assets
Total Assets	203	772	1,592	1,345	1,095
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	22.7	122	166	193	184
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	39.3	270	750	688	633
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	164	502	841	657	462
Total Liabilities & Shareholders' Equity	203	772	1,592	1,345	1,095
Total Common Shares Outstanding